Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
89.70
-8.80 (-8.93%)
At close: Apr 4, 2025, 4:00 PM
90.00
+0.30 (0.33%)
After-hours: Apr 4, 2025, 4:29 PM EDT
Boston Scientific Revenue
In the year 2024, Boston Scientific had annual revenue of $16.75B with 17.61% growth. Boston Scientific had revenue of $4.56B in the quarter ending December 31, 2024, with 22.44% growth.
Revenue (ttm)
$16.75B
Revenue Growth
+17.61%
P/S Ratio
8.65
Revenue / Employee
$315,981
Employees
53,000
Market Cap
132.67B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
BSX News
- 2 days ago - Goldman Sachs Thinks These Stocks Are ‘Insulated' From a Trade War - Barrons
- 3 days ago - Boston Scientific announces conference call discussing first quarter 2025 results - PRNewsWire
- 4 weeks ago - Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript) - Seeking Alpha
- 4 weeks ago - Boston Scientific announces agreement to acquire SoniVie Ltd. - PRNewsWire
- 5 weeks ago - Boston Scientific announces completion of €1.5 billion offering of senior notes - PRNewsWire
- 5 weeks ago - Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System - GlobeNewsWire
- 5 weeks ago - Boston Scientific announces pricing of €1.5 billion of senior notes - PRNewsWire
- 6 weeks ago - Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference - PRNewsWire